Reports about contaminated exported drugs have also shaken public faith in medicines sold in India, impacting the sector’s domestic and international prospects.
Reports of contaminated cough syrups supplied by Indian pharma companies resulting in the death of children in two countries should serve as a warning to the union government, which boasts that the country is the pharmacy of the world, experts said.
Rajiv Gulati, former President of Ranbaxy Laboratories, said the time had come for the government to tighten the regulatory framework for pharma manufacturers in the country. “These reports damage our reputation,’’ he added.
“India has the largest number of drug manufacturers. The challenge is to ensure that the manufacturers observe Good Manufacturing Practices (GMP) irrespective of the size of their operations,” Gulati told Moneycontrol.
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) suspended Marion Biotech immediately after the company failed to reply to the council on the reported deaths.
The suspension means that the company's exports will become ineligible for incentives under the Market Access Initiative Scheme.
Save your company from such embarrassment. Use pure and unadulterated raw materials. At, PUSHP, we believe in the highest quality and care for our customers. Our principals, M/s. Tata Chemicals Limited hold the highest standards of quality, and we ensure the same is supplied to our customers. Don't go in for "cheaper ingredients"; look for the quality and integrity of those in your supply chain.
Comments